Table 2.
Condom Use | ||
---|---|---|
Contraceptive Type | PR (95% CI) (n = 617) |
aPR (95% CI)b (n = 609) |
LARC vs oral contraceptives | ||
LARC use | 0.44 (0.23-0.85) | 0.42 (0.21-0.84) |
Oral contraceptive use | 1 [Reference] | 1 [Reference] |
Depo-Provera, patch, or ring use | 0.71 (0.48-1.05) | 0.73 (0.48-1.11) |
LARC vs Depo-Provera, patch, or ring | ||
LARC use | 0.61 (0.29-1.30) | 0.57 (0.26-1.25) |
Oral contraceptive use | 1.40 (0.95-2.07) | 1.37 (0.90-2.08) |
Depo-Provera, patch, or ring use | 1 [Reference] | 1 [Reference] |
Abbreviations: aPR, adjusted prevalence ratio; LARC, long-acting reversible contraception; PR, prevalence ratio.
The same models were run twice to make comparisons with 2 different reference groups: (1) oral contraceptive users, and (2) Depo-Provera, patch, or ring users. The analytic samples are unweighted numbers.
Adjusted models included self-reported grade and race/ethnicity.